Rebound Intracranial Hypertension: A Complication of Epidural Blood Patching for Intracranial Hypotension

References

1. 1.↵
   1. Mokri B

   . Spontaneous low pressure, low CSF volume headaches: spontaneous CSF leaks. Headache 2013;53:1034–53

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Sencakova D,
   2. Mokri B,
   3. McClelland RL

   . The efficacy of epidural blood patch in spontaneous CSF leaks. Neurology 2001;57:1921–23

   CrossRef
3. 3.↵
   1. Berroir S,
   2. Loisel B,
   3. Ducros A,
   4. et al

   . Early epidural blood patch in spontaneous intracranial hypotension. Neurology 2004;63:1950–51

   CrossRef
4. 4.↵
   1. Mokri B

   . Intracranial hypertension after treatment of spontaneous cerebrospinal fluid leaks. Mayo Clinic Proc 2002;77:1241–46

   CrossRefPubMed
5. 5.↵
   1. Farb RI,
   2. Forghani R,
   3. Lee SK,
   4. et al

   . The venous distension sign: a diagnostic sign of intracranial hypotension at MR imaging of the brain. AJNR Am J Neuroradiol 2007;28:1489–93

   Abstract/FREE Full Text
6. 6.↵
   1. Schievink WI

   . Spontaneous spinal cerebrospinal fluid leaks and intracranial hypotension. JAMA 2006;295:2286–96

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Dunn LT

   . Raised intracranial pressure. J Neurol Neurosurg Psychiatry 2002;73(Suppl 1):i23–27

   FREE Full Text
8. 8.↵
   1. Sergott RC

   . Headaches associated with papilledema. Curr Pain Headache Rep 2012;16:354–58

   CrossRefPubMed
9. 9.↵
   1. Valdueza JM,
   2. von Munster T,
   3. Hoffman O,
   4. et al

   . Postural dependency of the cerebral venous outflow. Lancet 2000;355:200–01

   PubMedWeb of Science
10. 10.↵
    1. Nilsson C,
    2. Ståhlberg F,
    3. Gideon P,
    4. et al

    . The nocturnal increase in human cerebrospinal fluid production is inhibited by a beta 1-receptor antagonist. Am J Physiol 1994;267:R1445–48
11. 11.↵
    1. Leep Hunderfund AN,
    2. Mokri B

    . Second-half-of-the-day headache as a manifestation of spontaneous CSF leak. J Neurol 2012;259:306–10

    CrossRefPubMed
12. 12.↵
    1. Cestari DM,
    2. Rizzo JF

    . Intracranial hypertension following epidural blood patch. Neurology 2003;61:1303
13. 13.↵
    1. Lin W-C,
    2. Lee M-H,
    3. Kao Y-F,
    4. et al

    . Monitoring rebound intracranial hypertension by cine MRI after treatment of spontaneous intracranial hypotension in a patient with notable subdural hemorrhage. Eur J Radiol Extra 2009;69:e1–e4

    CrossRef
14. 14.↵
    1. Tsui H,
    2. Wu S,
    3. Kuo H,
    4. et al

    . Rebound intracranial hypertension after treatment of spontaneous intracranial hypotension. Eur J Neurol 2006;13:780–82

    CrossRefPubMed
15. 15.↵
    1. Philipps J,
    2. Busse O

    . From low to high: late-onset intracranial hypertension after treatment of spontaneous intracranial hypotension. J Neurol 2007;254:956–57

    CrossRefPubMed
16. 16.↵
    1. Whiteley W,
    2. Al-Shahi R,
    3. Warlow CP,
    4. et al

    . CSF opening pressure: reference interval and the effect of body mass index. Neurology 2006;67:1690–91

    CrossRef
17. 17.↵
    1. Medina JH,
    2. Abrams K,
    3. Falcone S,
    4. et al

    . Spinal imaging findings in spontaneous intracranial hypotension. Am J Roentgenol 2010;195:459–64

    CrossRefPubMed
18. 18.↵
    1. Johanson CE,
    2. Murphy VA

    . Acetazolamide and insulin alter choroid plexus epithelial cell [Na+], pH, and volume. Am J Physiol 1990;258:F1538–46
19. 19.↵
    1. Ball AK,
    2. Clarke CE

    . Idiopathic intracranial hypertension. Lancet Neurol 2006;5:433–42

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Celebisoy N,
    2. Gökçay F,
    3. Sirin H,
    4. et al

    . Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand 2007;116:322–27

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Shah VA,
    2. Fung S,
    3. Shahbaz R,
    4. et al

    . Idiopathic intracranial hypertension. Ophthalmology 2007;114:617.e611–617.e612
22. 22.↵
    1. Lee AG,
    2. Anderson R,
    3. Kardon RH,
    4. et al

    . Presumed “sulfa allergy” in patients with intracranial hypertension treated with acetazolamide or furosemide: cross-reactivity, myth or reality? Am J Ophthalmol 2004;138:114–18

    CrossRefPubMedWeb of Science